KCNT1 and epilepsy: Recent studies identified KCNT1 as a novel driver of pathogenesis in some types of refractory epilepsy (e.g., epilepsy of infancy with migrating focal seizures, autosomal dominant nocturnal frontal lobe epilepsy, West syndrome, Ohtahara syndrome, early myoclonic encephalopathy, focal epilepsy, and multifocal epilepsy) (4–6).